Management ChangeMay 29, 2026, 05:07 PM
Tempest Therapeutics Director Simantov Resigns
AI Summary
Ms. Simantov resigned from the Board of Directors of Tempest Therapeutics, Inc. on May 23, 2026. The company stated that her resignation was not due to any disagreement regarding its operations, policies, or practices. In connection with her departure, a Separation Agreement was executed, under which Ms. Simantov waived all accrued and unpaid retainer fees. Her rights related to stock options, share ownership, and indemnification remain intact.
Key Highlights
- Director Ms. Simantov resigned from Tempest Therapeutics' Board.
- Resignation was effective May 23, 2026.
- No disagreement with company operations or policies was cited.
- A Separation Agreement was executed with Ms. Simantov.
- Ms. Simantov waived all accrued and unpaid retainer fees.
- Stock option awards and share ownership rights remain unaffected.
- Indemnification agreement remains in effect for six years.
Price Impact
More from TPST